Literature DB >> 21638068

A case of malignant hyperthermia captured by an anesthesia information management system.

Michael D Maile1, Rajesh A Patel, James M Blum, Kevin K Tremper.   

Abstract

Many cases of malignant hyperthermia triggered by volatile anesthetic agents have been described. However, to our knowledge, there has not been a report describing the precise changes in physiologic data of a human suffering from this process. Here we describe a case of malignant hyperthermia in which monitoring information was frequently and accurately captured by an anesthesia information management system.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21638068     DOI： 10.1007/s10877-011-9285-1

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN： 1387-1307            Impact factor:   2.502


  10 in total

1.  Several interacting genes influence the malignant hyperthermia phenotype.

Authors:  Rachel Robinson; Philip Hopkins; Antonella Carsana; Hermann Gilly; Jane Halsall; Luc Heytens; Gunilla Islander; Karin Jurkat-Rott; Clemens Müller; Marie-Anne Shaw
Journal:  Hum Genet       Date:  2002-11-15       Impact factor: 4.132

2.  Automated charting of physiological variables in anesthesia: a quantitative comparison of automated versus handwritten anesthesia records.

Authors:  J G Lerou; R Dirksen; M van Daele; G M Nijhuis; J F Crul
Journal:  J Clin Monit       Date:  1988-01

3.  Prediction of malignant hyperthermia susceptibility by clinical signs.

Authors:  M G Larach; H Rosenberg; D R Larach; A M Broennle
Journal:  Anesthesiology       Date:  1987-04       Impact factor: 7.892

Review 4.  Malignant hyperthermia: a review of published cases.

Authors:  K P Strazis; A W Fox
Journal:  Anesth Analg       Date:  1993-08       Impact factor: 5.108

Review 5.  The PaCO2 rate of rise in anesthetized patients with airway obstruction.

Authors:  M C Stock; J Q Schisler; T D McSweeney
Journal:  J Clin Anesth       Date:  1989       Impact factor: 9.452

Review 6.  Can anesthesia information management systems improve quality in the surgical suite?

Authors:  Jaume Balust; Alex Macario
Journal:  Curr Opin Anaesthesiol       Date:  2009-04       Impact factor: 2.706

7.  Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005.

Authors:  Eric B Rosero; Adebola O Adesanya; Carlos H Timaran; Girish P Joshi
Journal:  Anesthesiology       Date:  2009-01       Impact factor: 7.892

Review 8.  Dantrolene--a review of its pharmacology, therapeutic use and new developments.

Authors:  T Krause; M U Gerbershagen; M Fiege; R Weisshorn; F Wappler
Journal:  Anaesthesia       Date:  2004-04       Impact factor: 6.955

Review 9.  The role of the skeletal muscle ryanodine receptor (RYR1) gene in malignant hyperthermia and central core disease.

Authors:  D H MacLennan; M S Phillips
Journal:  Soc Gen Physiol Ser       Date:  1995

10.  Dantrolene in human malignant hyperthermia.

Authors:  M E Kolb; M L Horne; R Martz
Journal:  Anesthesiology       Date:  1982-04       Impact factor: 7.892
  10 in total
  2 in total

1.  Documentation and Treatment of Intraoperative Hypotension: Electronic Anesthesia Records versus Paper Anesthesia Records.

Authors:  Torin D Shear; Mark Deshur; Brittany Lapin; Steven B Greenberg; Glenn S Murphy; Joseph Szokol; Michael Ujiki; Rebecca Newmark; Jessica Benson; Cody Koress; Connor Dwyer; Jeffery Vender
Journal:  J Med Syst       Date:  2017-04-11       Impact factor: 4.460

2.  Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.

Authors:  Barbara W Brandom; Saiid Bina; Cynthia A Wong; Tarina Wallace; Mihaela Visoiu; Paul J Isackson; Georgirene D Vladutiu; Nyamkhishig Sambuughin; Sheila M Muldoon
Journal:  Anesth Analg       Date:  2013-04-04       Impact factor: 5.108
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.